Table 2.
All patients, n (%): N=30 | ||
---|---|---|
Angiographic outcomes | n-BCA group | Onyx group |
n=12 | n=18 | |
Initial volume, mL | ||
Median (Q1, Q3) | 3.5 (1.1, 9.9) | 4.3 (1.9, 11) |
Total % devascularization | ||
Median (Q1, Q3) | 52 (31, 67) | 51 (27, 86) |
<25%, n (%) | 2 (17) | 3 (17) |
25-49% | 3 (25) | 5 (28) |
50-75% | 5 (42) | 4 (22) |
75-99% | 1 (8) | 5 (28) |
>99% | 1 (8) | 1 (5) |
Need for >1 embolization | ||
Yes, n (%) | 6 (50) | 4 (22) |
Total number of sessions | ||
n | 22 | 25 |
Number of sessions per person | ||
Mean±SD | 1.8±1.0 | 1.4±0.8 |
Total number of pedicles | ||
n | 42 | 45 |
Number of pedicles per person | ||
Mean±SD | 3.5±1.9 | 2.6±2.0 |
Number of pedicles per session | ||
Mean±SD | 2.1±0.9 | 1.9±1.1 |
% devascularization per pedicle | ||
Mean±SD | 16±14 | 34±29 |
% devascularization by objective | Both groups:Mean±S``D | n=30 |
Curative (n=6) | 61±34 | |
Non-Curative: Palliative (n=1) | 79±N/A | |
Non-Curative: Targeted (n=5) | 48±19 | |
Non-Curative: Pre-surgery (n=12) | 47±29 | |
Non-Curative: Pre-SRS (n=6) | 54±36 | |
Complications, n (%) | n-BCA group | Onyx group |
n=12 | n=18 | |
Minor | 1 (8.3) | 0 (0) |
Major | 1 (8.3) | 0 (0) |
Mortality | 0 (0) | 0 (0) |
Total | 2 (17) | 0 (0) |
Note: Summary of the embolization objectives, angiographic changes, and complication rates associated with embolization treatments.
n-BCA, n-butyl cyanoacrylate; SRS, stereotactic radiosurgery